Skip to content
Recall Observatory FDA recall evidence

Drug product

Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-04

D-0115-2026

October 15, 2025

Class II

Product summary

Firm
ProRx LLC
Event
Event 97808
Status
Ongoing
Classification
Class II
Quantity
8,400 vials
Official record key
drug-enforcement:D-0115-2026

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot, Best Use Date (BUD): Lot PRORX050925-1, BUD November 4, 2025; Lot ProRx051425-5, BUD November 10, 2025; Lot ProRx051425-6, BUD November 10, 2025

Distribution pattern: TX and UT

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility